The long-term goal of the proposed research is to define the metabolic causes of cancer cachexia by using 13 nuclear magnetic resonance spectroscopy (NMRS). Though weight loss continues to be one of the more common symptoms in cancer patients, the precise nature of metabolic alterations in cancer cachexia has yet to be defined. The paucity of information concerning the specific metabolic changes in the individual organ systems has been a significant obstacle to the effective treatment of patient wasting in cancer. However, with the recent application of NMRS to biological systems, it has become possible to examine tissue metabolism in intact organs. In our initial study of the livers of tumor rats, we found that hepatic uptake and metabolism of alanine were markedly increased, and the concomitant increase in glucose production was limited. We believe this indicates a less effective gluconeogenic process than that in the normals. That is, for a given quantity of glucose production, more substrates are required through lipolysis or protein catabolism, and energy expenditure may be increased during the process. This """"""""ineffective"""""""" utilization of gluconeogenic substrates is probably a significant factor in the weight loss observed in cancer patients. We plan to delineate the """"""""ineffectiveness"""""""" of glucose production from alanine, glycerol and lactate using NMRS, first in the perfused livers, then in the in situ livers, of tumor bearing rats. The substrate uptake, the Krebs cycle and the gluconeogenic pathway will be examined to define the specific site(s) of enzymatic alterations. Urea production will be monitored so that the energy requirement can be assessed. Accumulation of intracellular metabolites observed in NMR spectra will be confirmed by conventional analytic methods. Finally, the (in)effectiveness of glucose production will be defined in terms of the quantities of substrates and energy consumed, for a given amount of glucose produced.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA050710-06
Application #
2093944
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1989-09-01
Project End
1995-08-31
Budget Start
1993-09-01
Budget End
1995-08-31
Support Year
6
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Hektoen Institute for Medical Research
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60612
Liu, K J; Drucker, Y; Jarad, J (1995) Hepatic glycerol metabolism in tumorous rats: a 13C nuclear magnetic resonance study. Cancer Res 55:761-6
Liu, K J; Kleps, R; Henderson, T et al. (1991) 13C NMR study of hepatic pyruvate carboxylase activity in tumor rats. Biochem Biophys Res Commun 179:366-71
Liu, K J; Henderson, T O; Kleps, R A et al. (1990) Gluconeogenesis in the liver of tumor rats. J Surg Res 49:179-85